Vaxart Inc (VXRT) announces a major partnership with Dynavax and reports significant revenue growth, while navigating market ...

Vaxart ( ($VXRT) ) has released its Q3 earnings. Here is a breakdown of the information Vaxart presented to its investors. Vaxart, Inc. is a ...

Vaxart secures major Dynavax deal, extending cash runway to 2027. Get Q3 earnings insights, clinical progress, and outlook on innovative oral vaccines.

Entered into an exclusive license agreement with Dynavax for the Company’s COVID-19 oral pill vaccine candidate for potential cumulative proceeds ...

The UK Health Security Agency (UKHSA) has published the most recent data on norovirus, often referred to as the "winter ...

Norovirus causes vomiting and diarrhoea. While it's unpleasant, it typically clears up in about two days, according to NHS ...

Norovirus triggers symptoms such as vomiting and diarrhoea. While it can be extremely unpleasant, it typically resolves ...

ICMR’s nationwide lab network strengthens outbreak surveillance, detects deadly viruses early, and fortifies the country’s ...